Unitract rolls out
Tuesday, 15 July, 2008
The global product roll-out for Unilife's [ASX: UNI] Unitract 1mL safety syringes has begun.
To support the roll-out, Unilife has appointed strategic partner Kindly Enterprise Development (KDL) Group as distribution partner for a number of regions.
Unilife has already received and processed sales orders from KDL for the syringe.
KDL has been granted exclusive rights to sell the syringe in selected regions in China, the Middle East, Eastern Europe, Africa and Central and South America, and non-exclusive rights to sell them in Germany and Austria.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
